NICE responds to study on patient groups financial disclosures News item 23 February 2019 Pages: 2 - 2
Direct oral anticoagulants reduce costs compared with warfarin Clinical study 23 February 2019 Pages: 5 - 5
Early treatment cost effective in adolescents with chronic HCV Clinical study 23 February 2019 Pages: 6 - 6
Electronic feedback reduces antibacterial prescribing for RTIs Clinical study 23 February 2019 Pages: 7 - 7
Ezetimibe cost saving for prevention of CV events in T2DM Clinical study 23 February 2019 Pages: 9 - 9
Financial hardship in nonelderly US adults with atherosclerotic CVD Clinical study 23 February 2019 Pages: 10 - 10
Food allergy: substantial economic burden due to opportunity costs Review 23 February 2019 Pages: 11 - 11
HPV genotype screening with dual stain cytology cost effective Clinical study 23 February 2019 Pages: 12 - 12
HPV testing on self-collected vaginal samples cost effective Clinical study 23 February 2019 Pages: 13 - 13
Hyperthermic IP chemotherapy in ovarian cancer cost effective Clinical study 23 February 2019 Pages: 14 - 14
Inappropriate prescribing in elderly increases costs and AEs Clinical study 23 February 2019 Pages: 15 - 15
Industry payments to medical association board members Clinical study 23 February 2019 Pages: 16 - 16
Insulin degludec: small benefits in T2DM at high cost in China Clinical study 23 February 2019 Pages: 17 - 17
Insulin pump therapy more costly than insulin injections Clinical study 23 February 2019 Pages: 18 - 18
Intravitreal ranibizumab: QALY gains at acceptable cost in the UK Clinical study 23 February 2019 Pages: 19 - 19
Is active monitoring a cost-effective option in depression? Clinical study 23 February 2019 Pages: 20 - 20
Long-term OACs with management more costly than usual care Clinical study 23 February 2019 Pages: 21 - 21
Multiple daily insulin injections in T2DM: high disease burden Clinical study 23 February 2019 Pages: 23 - 23
NICE recommends pertuzumab for early HER2-positive breast cancer News item 23 February 2019 Pages: 24 - 24
Nusinersen not cost effective for spinal muscular atrophy Clinical study 23 February 2019 Pages: 25 - 25
Patient WTP for cosmetic outcomes of skin cancer surgery Clinical study 23 February 2019 Pages: 26 - 26
Potential Zika vaccine: acceptance high, WTP low in Indonesia Clinical study 23 February 2019 Pages: 27 - 27
Readmission common and costly after S. aureus bacteraemia Clinical study 23 February 2019 Pages: 28 - 28
Sarilumab cost effective for active rheumatoid arthritis Clinical study 23 February 2019 Pages: 29 - 29
Screening all people for HCV in detention centres cost effective Clinical study 23 February 2019 Pages: 30 - 30
Secukinumab cost-effective option in ankylosing spondylitis Clinical study 23 February 2019 Pages: 31 - 31
Substantial cost savings by better glycaemic control in T1DM Clinical study 23 February 2019 Pages: 32 - 32
Targeted surgery cost effective in prevention of ovarian cancer Clinical study 23 February 2019 Pages: 33 - 33
US health spend for commercially insured reaches "all-time high" Non-clinical study 23 February 2019 Pages: 34 - 34